Tumoral progression of human breast epithelial cells secreting FGF2 and FGF4SOUTTOU, B; GAMBY, C; CREPIN, M et al.International journal of cancer. 1996, Vol 68, Num 5, pp 675-681, issn 0020-7136Article

FGF2 as an autocrine growth factor for immortal human breast epithelial cellsSOUTTOU, B; HAMELIN, R; CREPIN, M et al.Cell growth and differentiation. 1994, Vol 5, Num 6, pp 615-623, issn 1044-9523Article

Relationship between serum concentrations of the Growth factor pleiotrophin and pleiotrophin-positive tumorsSOUTTOU, B; JUHL, H; HACKENBRUCK, J et al.Journal of the National Cancer Institute. 1998, Vol 90, Num 19, pp 1468-1473, issn 0027-8874Article

Serum levels of the angiogenic factor pleiotrophin in relation to disease stage in lung cancer patientsJÄGER, R; LIST, B; KNABBE, C et al.British journal of cancer. 2002, Vol 86, Num 6, pp 858-863, issn 0007-0920Article

Facteurs de croissance des cellules épithéliales de mastopathies et de carcinomes du sein en primoculture = Growth factor requirements of cultured epithelial cell from benign mastopathies and mammary carcinomasSALLE, V; SOUTTOU, B; MAGNIEN, V et al.Bulletin du cancer. 1992, Vol 79, Num 2, pp 133-140, issn 0007-4551Article

Receptor binding and biological effects of three ¹²⁵I-iodinated estrogen derivatives in human breast cancer cells (MCF-7)SOUTTOU, B; MORETTI, J.-L; GROS, J et al.Journal of steroid biochemistry and molecular biology. 1993, Vol 44, Num 2, pp 105-112, issn 0960-0760Article